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Over the last few years there has been an accumula-
tion of observations which indicate that there is a
humoral substance other than aldosterone which
influences renal sodium excretion. The findings by
numerous authors have demonstrated that this humor-
al factor increases the excretion of sodium in response
to expansion of the extracellular fluid (ECF) volume.
While experiments in this field have been mainly car-
ried out using animals, this mechanism may also
operate in man. This review first presents the evidence
for the hypothesis that there is such a hormone. We
have then allowed ourselves the privilege of putting
forward the evidence which suggests that this hormone
may be a neurosecretion, while acknowledging the
fact that this evidence is indirect. We are aware of the
possibility of being criticized for presenting what some
might regard as a biased review, but we feel that this
approach will stimulate further work in this field.
The suggestion that the hypothalamus might secrete
a substance which controls urinary sodium excretion
directly was advanced in 1957 by Smith [1]. He con-
sidered that the known mechanisms controlling the
renal excretion of sodium could not adequately explain
the changes in excretion of this ion which occurred
under different physiological conditions. He proposed
that the neurosecretory substance was antinatriuretic
and he stated, "The precise control of sodium balance
must be very old, probably dating back to the earliest
fresh water vertebrates. This circumstance leads to
the speculation that a primaeval antinatriuretic
hormone X may have been secreted by some part of
the neuraxis before the adenohypophysis and adrenal
cortical tissue acquired their importance in sodium
balance." [1].
The first basic experiment favoring the presence of
a circulating substance, other than aldosterone, which
influenced urinary sodium excretion was probably
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presented by de Wardener et al in 1961 [2]. It consisted
of a cross-circulation experiment between dogs. Both
dogs were given large amounts of aldosterone and
vasopressin in order to eliminate variations of these
hormones as influencing factors. The dog to which
saline was administered had a substantially greater
natriuresis than the other, although the eventual
dilutional changes in the blood of the two dogs and
the changes in arterial pressure, para-aminohippurate
(PAH) and inulin clearances were the same. Since
the dog with the volume expansion had the greater rise
in urinary sodium excretion, the authors suggested
that part of the natriuresis was induced by a change in
concentration of some circulating substance other
than aldosterone.
The hypothesis that there was such a humoral sub-
stance did not initially receive widespread acceptance.
Rather, there has been an emphasis on the subsequent
discovery that physical factors such as peritubular
capillary hydrostatic pressure and, possibly, plasma
oncotic pressure could influence sodium excretion.
It had always been appreciated by those who advanced
the humoral hypothesis that expansion of plasma
volume of dogs with large amounts of i.v. admini-
stered saline would induce large dilutional changes in
the composition of the blood, and that such gross
physical changes would make it difficult to discern a
humoral effect. In order to overcome this valid objec-
tion, many investigators designed experiments which
avoided changes in physical factors. The main modi-
fication introduced was to expand the volume of the
animal with blood which was in equilibrium with its
own, essentially by circulating the animal's blood
through a reservoir, initially containing 3% albumin
in Hartmann's solution. After circulation of the
blood for one hour through the reservoir, equilibra-
tion had occurred. The blood volume of the animal
could then be expanded with blood in equilibrium with
its own. The blood volume of the dog was thus en-
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hanced without adding any foreign substance and
without a change of plasma oncotic pressure or packed
cell volume (Bahiman et al [3]). In some experiments
the kidneys were either denervated or isolated and
perfused at constant pressure. Bahiman et a! [3]
maintained constant renal artery perfusion by placing
a snare around the aorta, and also denervated one
kidney. Tobian, Coffee and McCrea [4] and Kaloyan-
ides and Azer [5] used isolated kidneys from rats and
dogs, respectively, while Lichardus and Nizet [6]
transplanted a dog kidney into the neck. Despite
variations in technique with denervated kidneys per-
fused at constant pressure, all the various authors
reported an increase in sodium excretion on expansion
of the blood volume.
Thus, it appears that the kidneys, whether perfused
at the end of the artery'or via plastic tubes, are able
to respond to an increase in blood volume by increas-
ing sodium excretion. The only contact the denervated
kidney has with the rest of the body is via the blood
stream and, as the expansion of this volume is with
equilibrated blood, the factor influencing sodium
excretion must be some change in concentration of a
humoral agent.
The humoral component of the natriuretic effect of
blood volume expansion has also been admirably
confirmed in cross-circulation experiments [7, 8].
This phenomenon can be demonstrated only if the
initial blood volume expansion of the donor rat is
sustained by continuously reinfusing its urine back into
its circulation [7]; otherwise, the blood volume falls and
the humoral component is at an insufficient level to
induce natriuresis in the recipient.
These experiments did not, however, provide defini-
tive information on how this humoral agent acts.
Even though it was clear that the humoral component
of blood volume expansion can be demonstrated at a
time when the renal blood flow and glomerular filtra-
tion rate are falling (Kaloyanides and Azer [5]), it
was not clear whether the hormone acted by altering
intrarenal hemodynamics, or by directly inhibiting
sodium transport in the proximal or distal tubules, or
the collecting ducts. In favor of a direct action of the
hormone on sodium transport was the finding of
Nutbourne et al [9]. In their experiments it was shown
that the blood from a dog undergoing natriuresis
induced by expansion of volume with equilibrated
blood induced a fall of short circuit current across the
isolated perfused frog's skin. The fall of short circuit
current is an index that active sodium transport had
decreased. The authors concluded that there is a sub-
stance circulating in the blood of a volume-expanded
dog which influences sodium transport, and that a
change in the concentration of this substance may be
responsible for part of the natriuresis caused by blood
volume expansion. In an endeavor to determine
whether this humoral messenger could influence ionic
movements in renal tubular cells, in vitro experiments
were carried out by Clarkson, Talner and de War-
dener [10]. They used fragments of renal tubules
(mainly proximal) incubated in plasma from dogs
before and during volume expansion. Incubation in
plasma from dogs with blood volume expansion re-
sulted in higher intracellular sodium and lower potas-
sium concentrations in these tubular fragments. This
result was considered to be an indication that the
plasma contained a substance which inhibited sodium
transport. Other workers have claimed that urine or
dialysate samples of blood from volume-expanded
animals inhibit sodium transport in vitro or increase
urine sodium excretion when given to another animal
[11—14].
It is appreciated that these in vitro experiments are
always subject to criticism in that the results obtained
are from preparations which are far removed from the
normal physiological state. However, there remains
the observations that animals with volumes expanded
with equilibrated blood do have a natriuresis and that
this appears to be mediated by humoral transmitter.
It is relevant to consider comparative physiology
in the elucidation of such a problem, and, therefore,
evidence supporting the view that sodium may be
actively excreted from an organism will now be
considered. This manner of approach is an example
which Smith [1] himself always felt to be a reasonable
one. There are invertebrate examples which provide
evidence of enhanced sodium excretion either because
of increased blood volume or of a change in the
environment. In the former case there is the classical
example of Rhodnius prolixus (sometimes referred to
as the assassin bug) which is a vector of Trypano-
soma cruzi. The urinary system consists of four blind-
ended malpighian tubules which float in the hemo-
lymph of the abdominal cavity. The formation of
urine is therefore entirely one of active secretion from
the hemolymph into the lumen of the malpighian
tubules. The morphology of the tubular wall is similar
to that of the proximal tubule in man except that
there are many mitochondria in the brush border.
When this insect has a meal, it sucks up to ten times
its own weight of blood. This is an acute volume ex-
pansion with a vengeance. The ingestion of blood
distends the insect's abdominal cavity and stretches
a set of lateral abdominal muscles. This in turn stimu-
lates intramuscular nerve endings, thereby increasing
the rate of afferent impulses which are transmitted to
a fused ganglionic mass situated in the mesothorax.
Within this portion of the central nervous system,
Neurosecretion and sodium excretion 325
there are neurosecretory cells. These contain a sub-
stance which is released into the hemolymph when the
abdominal cavity is distended. This substance produces
a massive increase in urinary sodium by the active
extrusion of this ion into the tubular system [15—17].
Another fascinating example is that of the prawn (the
brine shrimp). If the concentration of sodium chloride
in seawater is increased to the point at which sodium
begins to precipitate out of the solution (for example,
in the extraction process of salt from seawater), this
invertebrate is able to survive in the resulting environ-
ment of high salt concentration which one might
think would preclude the existence of any cellular
function. It is able to live because it can actively pump
sodium out of the gills against this gradient. If the
gills are destroyed, this prawn is still able to live in
seawater, but it is no longer able to survive in this
incredibly high concentration of sodium chloride [18].
Here we thus have two intriguing examples of inverte-
brate organisms maintaining homeostasis by the pro-
cess of pumping sodium into the exterior; this is
certainly due to a neurosecretion in the Rhodnius
prolixus.
When moving from the invertebrate to the verte-
brate class, it would be reasonable to seek in the latter
an analogous organ to the neurohemal one. Indeed,
such a gland does exist in the vertebrate series—the
posterior pituitary gland, or in some fish the urophysis
[19]. In the teleosts, the urophysis (the structure of
this tissue is essentially similar to that of the neuro-
hypophysis) is ideally situated to control the kidneys,
since the venous drainage empties into the caudal
vein and, thereby, into the renal portal system [20].
It has been shown that extracts of the urophysis not
only reduce sodium excretion by the kidney but may
also stimulate sodium transport outwards across the
gill [21]. While it is true that fish possess aldosterone,
the quantity present is so small that it is very doubtful
that it plays any part in the regulation of sodium balance
[22]. Bern [20], discussing this aspect, even excludes
the existence of aldosterone in this class. It would
seem that here it is the urophysis which controls sodi-
um excretion and one of its actions is the active extru-
sion of sodium from the cells to the exterior.
If one now considers the amphibians and reptiles,
where the urophysis is absent, it is necessary to con-
sider the part played by the neurohypophysis. Here it is
generally accepted that vasotocin increases tubular
reabsorption of sodium [23, 24]. These classes are
examples in which a hormone increases tubular reab-
sorption, whereas in the higher vertebrates and in
man, one is seeking for a hormone which either blocks
sodium reabsorption or promotes sodium secretion.
Hence, it is interesting to record that marine birds
possess the ability to actively secrete sodium and this
is achieved by the nasal glands [25]. It will be recalled
that birds cannot excrete high salt concentrations in
the urine and so sodium balance appears to be main-
tained by this unusual mechanism. While this does not
directly support the possibility of sodium secretion by
the mammalian kidney, it does provide evidence for
the existence of such a sodium-excreting mechanism
elsewhere.
Because neurohypophysial hormones have been
reported to influence sodium excretion, these hormones
have been considered to be possible candidates for the
hormonal factor responsible for the natriuresis of
volume expansion. The effect of neurohypophysial
hormones on sodium excretion has been the subject
of much controversy for many years, some authors
claiming that these hormones increase sodium excre-
tion in the mammalian series (with particular reference
to man) while others deny it. This aspect is therefore
considered in some detail.
Shannon [26] showed that infusions of neurohypo-
physial extracts containing both vasopressin and
oxytocin (less than 20 mU/hr of Pituitrin/100 g) to
rats given water, 0.05% saline or Ringer's solution
induced natriuresis. In man, it is generally accepted
that Pituitrin extracts produce no effect on renal
sodium excretion, although in 1936 Smith and Mac-
kay [27] found that natriuresis occurred during the
first two days of treatment with 0.5 ml of "Pituitrin
surgical" daily in normal men.
Sawyer [28] found that doses above 10 mU/100 g
of Pitressin (vasopressin extract of the neurohypo-
physis) administered subcutaneously to rats caused
natriuresis, while Schroder et al [29] showed that doses
of 100 U were sufficient to produce this change in
hydrated rats. Natriuresis was produced in dogs with
doses of Pitressin, 8 mU/kg [30]; in hydrated dogs
Pitressin infusions of 15 to 20 mU/hr increased sodium
excretion [31]. In addition, Chan and Sawyer [32]
found that injections of large doses of Pitressin to hy-
drated and dehydrated dogs resulted in natriuresis, and
in 1962 they [33] confirmed that infusions of Pitressin
to hydrated dogs could also cause natriuresis, albeit
transient. In humans, considerable natriuresis was
observed in two boys following a subcutaneous injec-
tion of Pitressin, by Manchester in 1932 [34].
In 1952, Sawyer [28] showed that subcutaneously
administered doses of more than 10 mU of Pitocin
(oxytocin extracts of the neurohypophysis) to rats
given 0.05% NaC1 resulted in increased excretion of
sodium. Similarly, Brunner et al [35] found increased
sodium excretion in rats treated with 31 and 125 mU
of oxytocin (Orasthin, Hoeschst) administered sub-
cutaneously.
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Highly purified arginine-vasopressin administered
in supramaximal antidiuretic doses to dogs in water
diuresis caused natriuresis, whereas in lightly hydrated
dogs, no such effect was observed [36]. Highly purified
lysine vasopressin, on the other hand, has not been
shown to have any effect on sodium excretion in
dogs [37] or man [38].
Barnafi et al [39] showed that both synthetic argi-
nine and lysine vasopressins injected subcutaneously
increased renal excretion of sodium and potassium in
rats loaded with a solution of NaCI and KCL. Chan
[40] found slight natriuresis when synthetic lysine
vasopressin was administered to hydrated rats, while
Atherton, Hai and Thomas [41] showed that this
effect was transient.
Brooks and Pickford [36] found that highly purified
oxytocin administered simultaneously with vasopressin
to dogs either in water diuresis or antidiuresis resulted
in an increased rate of excretion of sodium and potas-
sium. Oxytocin alone administered i.v. during a water
diuresis in dogs failed to increase sodium excretion.
Natriuresis was observed, however, when oxytocin
was injected i.v. in large or small doses into the carotid
artery of dogs with a low rate of urine flow. This
finding indicated that there might be a hormonal
action via the central nervous system to induce this
enhanced excretion of salt by a mechanism other than
by the known neurohypophysial hormones.
Croxatto and Labarca [42] showed that administra-
tion of synthetic oxytocin increases renal excretion of
sodium in rats. Doses of synthetic oxytocin, 2.5 and
5.0 mU, injected subcutaneously into rats loaded with
NaCl and KCI solution increased renal excretion of
sodium and potassium [40, 43, 44]. In hydrated and
dehydrated dogs, administration of large doses of
Syntocinon produced natriuresis [32].. However,
Schrier et a! [45] were unable to implicate oxytocin
as the natriuretic hormone involved in the natriuresis
of volume expansion in dogs. An earlier report by
Thomson [46] showed that oxytocin was not a natri-
uretic factor in man and this has now been generally
accepted. However, there is the report of Holecek
and Horkey [47], even though it is highly conjectural,
that when patients with premenstrual edema (which
was assumed to be due to excess vasopressin secretion
inducing slight retention) were given oxytocin, natri-
uresis occurred.
One cannot better the conclusions reached by Bent-
ley in 1971 [23] that in mammals the neurohypophysial
hormones may, in an unpredictable way, increase
sodium excretion in the rat, dog, camel and sheep, but
not man. Vasopressin is secreted in response to a fall
of fluid volume and is, therefore, unlikely to be in-
volved in the natriuresis of volume expansion. Never-
theless, the natriuretic action of this hormone should
not be ignored. It is possible that an octapeptide of
similar structure, as yet unidentified, may exist whose
natriuretic action could justify its classification as the
"natriuretic hormone".
Apart from the neurohypophysial hormones, what
possible known chemical messenger could the un-
known hormone be? The search has exposed the
natriuretic properties of several substances, including
prostaglandins [48], calcitonin [49], alpha-melanocyte-
stimulating hormone [50], kallikreins [51], prolactin
[52] and insulin [53], and parathyroid hormone [54].
However, it is accepted that there are several objections
to any of these circulating substances being the un-
known hormone which increases sodium excretion in
response to an expansion of body fluids.
Some of the evidence that the unknown natriuretic
hormone may arise from the brain is provided by the
work of Cort et al [55]. They found that there was a
natriuretic substance in the jugular venous blood
following carotid arterial occlusion which was chemi-
cally related to, but probably not, oxytocin and which
originated from the posterior hypothalamic region.
Subsequently, in 1969, Sedláková, Lichardus and Cort
[56] suggested that oxytocin and certain analogues
caused the release of another peptide of small mol
wt from some intracranial structure. This substance
acted on the kidney to increase sodium rejection.
This finding would account for the earlier observation
by Brooks and Pickford [36].
Another finding favoring the hypothesis that the
natriuretic hormone comes from the brain has been
described by Lockett [57]. A cat kidney was perfused
at a constant pressure with a heart-lung preparation.
The blood used in the perfusion circuit came from
either a normal or a headless cat, that is, an animal in
which the brachiocephalic and left subclavian arteries
had been ligatured. Lockett found that the addition of
10 ml of saline to the 120 ml of blood perfusing the
kidney caused an increase in sodium excretion only if
the blood came from a normal animal, whereas if the
blood perfusing the kidney was taken from a headless
animal, the addition of 10 ml of saline did not cause
a rise in sodium excretion. Lockett's conclusions about
these experiments are inescapable. "The responses
given by the isolated cat kidney to dilution of the
circulating blood with saline are not attributable to
changes in the concentration of plasma proteins or the
haematocrit or to activation of plasma kinins because
dilution of blood from headless donors with saline
caused no change in the parameters measured." And
"It is evident that the hormone responsible for the
reduction in renal Na transport in response to salt
loading is dependent on the presence of a hormone of
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intracranial origin, either for its release or for its
effect."
In 1957 Smith [1] had already suggested that the
hypothalamus in man might secrete a substance which
controls sodium excretion. Indeed, we would suggest
that the original conception of Smith still applies
today.
There is some indirect evidence to support the
suggestion that the hypothalamus may be the site of
the natriuretic hormone. Electrolytic lesions of the
posterior hypothalamus diminish the natriuretic res-
ponse to volume expansion [58, 59]. In addition, it is
not unreasonable to assume that sodium balance
should be controlled from a neural area closely related
to that which regulates water balance, since both are
mutually related in the regulation of body volumes.
Conroy and Mills [60] have shown that there is a diur-
nal variation of urinary sodium excretion in man,
although the mechanism whereby this is induced is
unknown. However, since the diurnal variation of
plasma adrenocorticotropic hormone (ACTH) is
controlled by the hypothalamus [61], we should like
to advance the hypothesis that the diurnal variation
of sodium excretion is also controlled by this part of
the brain, and that it exerts this control not via the
adrenals, but by a chemical messenger acting directly
on the renal tubular cells. As this substance would be
released by nerve endings directly into the blood
system to act on a distant organ, it would be a neuro-
secretion. Furthermore, we would suggest that this
substance may be the unidentified natriuretic hormone.
It is worthy to note that the sodium-retaining agent
vasotocin was originally regarded as an interesting
analogue of one of the mammalian neurohypophysial
hormones before it was appreciated that this hormone
was a natural secretion of the lower vertebrates. Of
interest is the fact that another analogue of the neuro-
hypophysial hormones, namely 4-Leucine-arginine
vasopressin, is a potent natriuretic substance [62].
While the unidentified natriuretic hormone cannot be
oxytocin or vasopressin, it would be tempting to
speculate that a similar substance is synthetized in the
hypothalamic region. This speculation gains indirect
support from the interesting claim that vasotocin may
be found in the pituitary glands of fetal sheep and
seals [63]. More direct evidence is the recent finding
that there is a natriuretic substance in the posterior
pituitary [64] and in the hypothalamic region [65]
which is not vasopressin or oxytocin.
The final section of this review will be devoted to
the site of action in the tubular system of this unknown
hormone and whether the hormone acts by decreasing
sodium reabsorption or by increasing sodium secretion.
It must be emphasized that, in this review, only the
anatomical site of action of this hormone on the renal
tubular system is discussed. It will be for others to
determine whether this is of vascular or enzymatic
origin.
Volume expansion causes the inhibition of proximal
tubular sodium reabsorption, and the resulting increas-
ed amount of sodium which is delivered out of the
proximal tubule is more than sufficient to account for
the accompanying natriuresis [66]. For this reason,
the decrease in sodium reabsorption by the proximal
tubule was considered for some time to be the mechan-
ism by which sodium excretion increased after infusion
of saline. However, recent evidence has accumulated
which indicates that the proximal tubule may not
have as important a role in the regulation of sodium
excretion as was previously suggested [67—70].
By infusing hyperoncotic albumin solutions into
dogs, which cause an increase in plasma volume but
not of interstitial fluid volume, Howards et al [67]
were able to demonstrate that the preferential expan-
sion of plasma volume, although causing an inhibition
of proximal sodium reabsorption (measured by micro-
puncture of superficial nephrons) comparable with
that after extracellular volume expansion, produces
very little increase in sodium excretion.
A similar dissociation between proximal sodium
reabsorption and urinary sodium excretion has been
shown by measuring sodium excretion following
volume expansion both in the presence and absence
of decreased proximal reabsorption, in the same dogs
[69]. In these studies it was shown that volume expan-
sion with Ringer's solution had the expected effect of
inhibiting proximal sodium reabsorption and causing
increased fractional sodium excretion. However, the
subsequent infusion of hyperoncotic albumin solution
into the renal artery restored proximal sodium
reabsorption to control values, but 70% of the natri-
uresis remained. These results indicate that increased
delivery from the proximal tubule contributes only a
minor fraction to the increased sodium excretion.
Although these conclusions were based on results
from micropuncture experiments of superficial neph-
rons, which are subject to criticism in that changes in
superficial nephrons are not necessarily representative
of changes in deep nephrons, Knox et al [69] attemp-
ted to counter such criticism by measuring phosphate
excretion as an index of total proximal sodium reab-
sorption throughout the kidney. The use of phosphate
excretion is dependent on the assumption that the
bulk of phosphate reabsorption occurs in the proximal
tubule [71, 72] and that phosphate reabsorption is
closely related to proximal sodium reabsorption under
a variety of conditions [73, 74]. Knox et al [69] found
that fractional phosphate excretion was increased
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during Ringer's solution loading, but fell close to
control values after renal arterial albumin infusion,
indicating that changes in superficial nephron reab-
sorption were parallelled by changes in deep nehprons.
The natriuresis following volume expansion is,
thus, largely due to changes in sodium transfer at a
site distal to the proximal convoluted tubule. There is
some evidence for believing that the collecting duct
plays an important role. Sonnenberg [75] punctured
superficial distal convoluted tubules of the kidneys of
rats which had been chronically sodium- and DOCA-
loaded or had been chronically sodium-deprived. He
then repunctured the same sites following either
volume expansion with blood, or exchange of the
blood of the recipient with that of an unexpanded
donor animal. Although in both groups of animals
there was a large natriuresis in response to expansion,
there was little inhibition of sodium reabsorption up
to the end of the distal convoluted tubule. It was found
that end-distal sodium delivery in some "exchange-
transfusion" rats was comparable with the delivery
in some expanded animals (even though sodium
excretion was much higher in the latter). In addition,
the sodium excretion in the expanded, chronically
sodium-loaded rats was greater than the quantity of
sodium delivered from the distal tubules, suggesting
that the extra sodium was added to the collecting duct.
An alternative explanation could be the presence of a
disproportionate end-distal sodium load from deep
nephrons. However, as Sonnenberg pointed out, the
ratio of superficial nephron filtration rate to total
kidney glomerular filtration rate (GFR) in expanded
chronically sodium-loaded rats was 0.91, whereas in
expanded sodium deficient rats, it was 0.62; thus,
such an explanation is not tenable for the sodium-
loaded rats. While agreeing that the major site control-
ling sodium excretion is the collecting duct, other
investigators (for example, Stein et al [70]) have not
been able to produce evidence of sodium addition to
the tubular fluid, but suggest that the mechanism is
only an inhibition of sodium reabsorption in the
collecting duct. Stein et al [70] produced extracellular
volume expansion in one group of rats by administra-
tion of Ringer's solution, while into a second group
hyperoncotic albumin solution was infused, in order to
expand the intravascular volume only. Sodium excre-
tion was greater in the Ringer-loaded animals, but the
amount of sodium present at the end of the distal
tubule in both groups was similar, so that the differ-
ence in urinary sodium excretion between the two
groups was due to diminished handling of sodium in
the collecting ducts. As the amount of sodium excreted
in both groups was less than the amount delivered,
there was no evidence of sodium secretion. Unfortu-
nately, in these experiments volume expansion was
with saline, so the possibility that the collecting duct
changes were due to dilutional changes rather than
hormonal changes cannot be discounted. It is essential
that all experiments used in investigating the proper-
ties of the natriuretic hormone (on the kidney) should
be performed on isolated denervated kidneys per-
fused at constant pressure and that the animal
perfusing the kidney should have its blood volume
expanded with blood with which it is in equilibrium.
In conclusion, it would be fair to summarize the
situation by stating that the volume-expanded animal
has a natriuresis induced by an, as yet, unknown
mechanism; however, the present evidence would lend
support to the presence of a hormone; indeed, a
hormone which is probably not a known naturally
occurring substance. Although the evidence for this
unknown substance being of neurohypophysial origin
has been closely examined (and indeed, perhaps undue
emphasis placed on this possibility), it cannot be
confirmed. Since some analogues of the neurohypo-
physial hormones have a natriuretic action, the tenta-
tive hypothesis advanced is that such a substance is
synthetized in the hypothalamic region and that the
unknown hormone is therefore a neurosecretion.
Finally, although the evidence is far from complete,
it now appears possible that this hormone may act on
the renal distal nephron either to block reabsorption
of sodium or possibly to promote the active extrusion
of sodium.
Reprint requests to Dr. H. E. de Wardener, Department of
Medicine, Charing Cross Hospital Medical School, London W.6,
England.
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